These results highlighted the inhibition of lncRNA DLX6-AS1 could suppress tumorigenesis and tumor growth of LCSCs in vivo by suppressing the STAT3 signaling pathway after increasing CADM1. The gene discussed is DLX6; the disease is neoplasm.